Upgrade to SI Premium - Free Trial

Manhattan Associates Reports Second Quarter Results

July 28, 2026 4:05 PM

Cloud Revenue Increased 26% over Prior Year

RPO Increased 23% over Prior Year

ATLANTA--(BUSINESS WIRE)-- Leading Supply Chain and Omnichannel Commerce Solutions provider Manhattan Associates Inc. (NASDAQ: MANH) today reported revenue of $297.8 million for the second quarter ended June 30, 2026, compared to $272.4 million in Q2 2025. GAAP diluted earnings per share for Q2 2026 was $0.85 compared to $0.93 in Q2 2025. Non-GAAP adjusted diluted earnings per share for Q2 2026 was $1.39 compared to $1.31 in Q2 2025.

“Manhattan delivered record Q2 and first half results. On strong demand, we posted our third consecutive record bookings quarter and once again accelerated our revenue growth,” said Manhattan's President and CEO Eric Clark.

“While mindful of the continued global macro volatility, we are confident in our business momentum and our ability to deliver successful customer outcomes. As Manhattan’s product advantage continues to widen and our targeted go-to-market investments gain traction, we believe we are well positioned to continue to gain market share in the large supply chain commerce market,” Mr. Clark concluded.

SECOND QUARTER 2026 FINANCIAL SUMMARY:

SIX MONTH 2026 FINANCIAL SUMMARY:

2026 GUIDANCE

Manhattan provides the following revenue, operating margin, and diluted earnings per share guidance for the full year 2026:

Guidance Range - 2026 Full Year

($'s in millions, except operating margin and EPS)

$ Range

% Growth Range

Total revenue

$1,160

$1,166

7%

8%

Operating Margin:

GAAP operating margin

24.2%

24.4%

Equity-based compensation

10.1%

10.1%

Restructuring expense (3)

0.7%

0.7%

Adjusted operating margin(1)

35.0%

35.2%

Diluted earnings per share (EPS):

GAAP EPS

$3.59

$3.65

0%

1%

Equity-based compensation

1.71

1.71

Tax deficiency of stock awards vested (2)

0.04

0.04

Restructuring expense (3)

0.10

0.10

Adjusted EPS(1)

$5.44

$5.50

8%

9%

(1) Adjusted operating margin and adjusted EPS are non-GAAP measures that exclude the impact of equity-based compensation,

expense related to an unusual health insurance claim, restructuring expense, and the related income tax effects, if applicable.

(2) The tax deficiency (benefit) on stock vesting occurred primarily in the first quarter of 2026.

(3) On June 1, 2026, we reduced our global headcount by approximately 6%, leveraging increased operational efficiencies and allowing us to focus investments on key strategic priorities. We recorded pre-tax restructuring expense in the second quarter of 2026 and exclude the amount from adjusted non-GAAP results.

Manhattan currently intends to make public certain expectations with respect to future financial performance. Those statements, including the guidance provided above, are forward looking. Actual results may differ materially. See our cautionary note regarding “forward-looking statements” below.

Manhattan will make this earnings release and a recording of the conference call referenced below available on the investor relations section of our website at ir.manh.com. Following publication of this earnings release, any expectations with respect to future financial performance contained in this release or the conference call, including the guidance, should be considered historical only, and Manhattan disclaims any obligation to update them.

CONFERENCE CALL

Manhattan’s conference call regarding its second quarter financial results will be held today, July 28, 2026, at 4:30 p.m. Eastern Time. We also will discuss our business and expectations for the year and next quarter in additional detail during the call. We invite investors to a live webcast of the conference call through the Investor Relations section of our website at ir.manh.com. To listen to the live webcast, please go to the website at least 15 minutes before the call to download and install any necessary audio software. The Internet webcast will be available until Manhattan Associates’ third quarter 2026 earnings release.

GAAP VERSUS NON-GAAP PRESENTATION

Manhattan provides adjusted operating income and margin, adjusted income tax provision, adjusted net income, and adjusted diluted earnings per share in this press release as additional information regarding our historical and projected operating results. These measures are not in accordance with, or alternatives to, GAAP, and may be different from similarly titled non-GAAP measures used by other companies. Manhattan believes the presentation of these non-GAAP financial measures facilitates investors’ ability to understand and compare our results and guidance, because the measures provide supplemental information in evaluating the operating results of our business, as distinct from results that include items not indicative of ongoing operating results, and because we believe our peers typically publish similar non-GAAP measures. This release should be read in conjunction with Manhattan's Form 8-K earnings release filing for the three and six months ended June 30, 2026.

Non-GAAP adjusted operating income and margin, adjusted income tax provision, adjusted net income, and adjusted diluted earnings per share exclude the impact of equity-based compensation, an expense – net of insurance recoveries, related to an unusual health insurance claim, and restructuring expense – net of income tax effects, collectively. They also exclude the tax benefits or deficiencies of vested stock awards caused by differences in the amount deductible for tax purposes from the compensation expense recorded for financial reporting purposes. We include reconciliations of Manhattan's GAAP financial measures to non-GAAP adjustments in the supplemental information attached to this release.

ABOUT MANHATTAN ASSOCIATES

Manhattan Associates is a global technology leader, providing supply chain and omnichannel commerce solutions with unmatched AI capabilities. We design, build and offer best-in-class, AI-powered, cloud-based solutions that drive resilience and efficiency for businesses. We enable enterprises to uniquely unify front-end sales with back-end supply chain execution.

Our commitment to innovation, cloud-native platform, and API-first architecture create simpler experiences and faster paths to value for our customers. We empower them to preempt and react to emerging trends and global disruptions with technical expertise and operational confidence, transforming challenges into competitive advantage. For more information, please visit www.manh.com.

This press release contains “forward-looking statements” relating to Manhattan Associates, Inc. Forward-looking statements in this press release include, without limitation, the information set forth under “2026 Guidance” and statements identified by words such as “may,” “expect,” “forecast,” “anticipate,” “intend,” “plan,” “believe,” “could,” “seek,” “project,” “estimate,” and similar expressions. Prospective investors are cautioned that any of those forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by those forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by those forward-looking statements are: economic conditions, including as a result of global instability due to military conflict, including the military conflict involving the United States, Israel, and Iran, as well as the ongoing war between Russia and Ukraine, disruption and transformation in the retail sector and our vertical markets; delays in product development; competitive and pricing pressures; software errors and information technology failures, disruption and security breaches; risks related to our products’ technology and customer implementations; risks associated with our use of generative and agentic artificial intelligence; and the other risk factors set forth in Item 1A of Manhattan's Annual Report on Form 10-K for the year ended December 31, 2025, and in Item 1A of Part II in subsequent Quarterly Reports on Form 10-Q. Manhattan undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results.

MANHATTAN ASSOCIATES, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(in thousands, except per share amounts)

Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

2026

2025

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Revenue:

Cloud subscriptions

$126,722

$100,422

$243,845

$194,728

Software license

1,923

1,528

4,157

10,820

Maintenance

30,523

35,057

61,115

67,201

Services

133,047

128,899

258,764

250,026

Hardware

5,579

6,515

12,128

12,433

Total revenue

297,794

272,421

580,009

535,208

Costs and expenses:

Cost of cloud subscriptions, maintenance and services

128,907

115,921

254,984

230,279

Cost of software license

556

294

1,120

503

Research and development

34,765

34,871

72,111

70,169

Sales and marketing

30,699

19,979

58,451

41,040

General and administrative

26,741

25,976

50,447

50,195

Depreciation and amortization

1,632

1,584

3,465

3,125

Restructuring expense

8,263

8

8,263

2,937

Total costs and expenses

231,563

198,633

448,841

398,248

Operating income

66,231

73,788

131,168

136,960

Other income, net

983

715

5,320

2,052

Income before income taxes

67,214

74,503

136,488

139,012

Income tax provision

16,862

17,723

36,841

29,650

Net income

$50,352

$56,780

$99,647

$109,362

Basic earnings per share

$0.86

$0.94

$1.68

$1.80

Diluted earnings per share

$0.85

$0.93

$1.67

$1.78

Weighted average number of shares:

Basic

58,760

60,612

59,221

60,741

Diluted

58,997

61,074

59,515

61,300

Reconciliation of Selected GAAP to Non-GAAP Measures

(in thousands, except per share amounts)

Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

2026

2025

Operating income

$66,231

$73,788

$131,168

$136,960

Equity-based compensation (a)

29,356

24,275

55,880

53,101

Unusual health insurance claim (c)

-

3,000

-

(658)

Restructuring expense (d)

8,263

8

8,263

2,937

Adjusted operating income (Non-GAAP)

$103,850

$101,071

$195,311

$192,340

Income tax provision

$16,862

$17,723

$36,841

$29,650

Equity-based compensation (a)

4,182

3,156

7,880

7,496

Tax (deficiency) benefit of stock awards vested (b)

(139)

61

(2,316)

3,603

Unusual health insurance claim (c)

-

724

-

(159)

Restructuring expense (d)

2,041

1

2,041

708

Adjusted income tax provision (Non-GAAP)

$22,946

$21,665

$44,446

$41,298

Net income

$50,352

$56,780

$99,647

$109,362

Equity-based compensation (a)

25,174

21,119

48,000

45,605

Tax deficiency (benefit) of stock awards vested (b)

139

(61)

2,316

(3,603)

Unusual health insurance claim (c)

-

2,276

-

(499)

Restructuring expense (d)

6,222

7

6,222

2,229

Adjusted net income (Non-GAAP)

$81,887

$80,121

$156,185

$153,094

Diluted EPS

$0.85

$0.93

$1.67

$1.78

Equity-based compensation (a)

0.43

0.35

0.81

0.74

Tax deficiency (benefit) of stock awards vested (b)

-

-

0.04

(0.06)

Unusual health insurance claim (c)

-

0.04

-

(0.01)

Restructuring expense (d)

0.11

-

0.10

0.04

Adjusted diluted EPS (Non-GAAP)

$1.39

$1.31

$2.62

$2.50

Fully diluted shares

58,997

61,074

59,515

61,300

a)

Adjusted results exclude all equity-based compensation, as detailed below, to facilitate comparison with our peers and for the other reasons explained in our Current Report on Form 8-K filed with the SEC. We do not receive a GAAP tax benefit for a portion of our equity-based compensation, mainly because of Section 162(m) of the Internal Revenue Code, which limits tax deductions for compensation granted to certain executives.

Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

2026

2025

Cost of services

$10,979

$10,513

$22,565

$21,938

Research and development

5,994

5,674

12,381

11,632

Sales and marketing

3,296

1,121

6,964

3,427

General and administrative

9,087

6,967

13,970

16,104

Total equity-based compensation

$29,356

$24,275

$55,880

$53,101

b)

Adjustments represent the excess tax benefits and tax deficiencies of the equity awards vested during the period. Excess tax benefits (deficiencies) occur when the amount deductible on our tax return for an equity award is more (less) than the cumulative compensation cost recognized for financial reporting purposes. As discussed above, we exclude equity-based compensation from adjusted non-GAAP results to be consistent with other companies in the software industry and for the other reasons explained in our Current Report on Form 8-K filed with the SEC. Therefore, we also exclude the related tax benefit (expense) generated upon their vesting.

c)

In the fourth quarter of 2024, we recorded $7.0 million of expense for an unusual health insurance claim. During the first quarter of 2025, we received an insurance recovery of $4.7 million for this claim, partially offset by $1.0 million of ongoing expense for the claim. During the second quarter of 2025, we recorded an additional $3.0 million of expense for this unusual health insurance claim. During the fourth quarter of 2025, we settled the remaining balance of the claim and recorded $6.2 million of benefit as the final payment was much lower than the cost estimates previously provided by our health insurance provider. Based on the uncommonly large magnitude and nature of the claim and timing of related insurance recoveries, we do not believe that this expense reflects our normal operating activities, and we have excluded the amount from adjusted non-GAAP results.

d)

Restructuring expense primarily consists of employee severance and outplacement services. On June 1, 2026, we reduced our global headcount by approximately 6% and recorded pre-tax restructuring expense in the second quarter of 2026 of approximately $8.3 million. In January 2025, we eliminated about 100 positions and recorded pre-tax restructuring expense in the first quarter of 2025 of approximately $2.9 million. We excluded these costs for adjusted non-GAAP results to facilitate period-to-period comparability of operating performance.

MANHATTAN ASSOCIATES, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

June 30, 2026

December 31, 2025

(unaudited)

ASSETS

Current assets:

Cash and cash equivalents

$

186,110

$

328,747

Accounts receivable, net

218,878

214,679

Prepaid expenses and other current assets

62,072

39,912

Total current assets

467,060

583,338

Property and equipment, net

24,606

23,120

Operating lease right-of-use assets

46,200

50,443

Goodwill, net

62,240

62,244

Deferred income taxes

50,860

75,900

Other assets

47,680

44,343

Total assets

$

698,646

$

839,388

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:

Accounts payable

$

30,733

$

22,182

Accrued compensation and benefits

70,961

69,309

Accrued and other liabilities

29,984

26,570

Deferred revenue

343,208

337,049

Income taxes payable

168

803

Total current liabilities

475,054

455,913

Operating lease liabilities, long-term

53,882

56,180

Other non-current liabilities

12,203

12,530

Shareholders' equity:

Preferred stock, no par value; 20,000,000 shares authorized, no shares issued or outstanding in 2026 and 2025

-

-

Common stock, $0.01 par value; 200,000,000 shares authorized; 58,300,070 and 59,845,291 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively

583

598

Retained earnings

193,950

345,097

Accumulated other comprehensive loss

(37,026

)

(30,930

)

Total shareholders' equity

157,507

314,765

Total liabilities and shareholders' equity

$

698,646

$

839,388

MANHATTAN ASSOCIATES, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(in thousands)

Six Months Ended June 30,

2026

2025

(unaudited)

(unaudited)

Operating activities:

Net income

$

99,647

$

109,362

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

3,465

3,125

Equity-based compensation

55,880

53,101

Gain on disposal of equipment

(162

)

(21

)

Deferred income taxes

24,706

(4,957

)

Unrealized foreign currency (gain) loss

(652

)

1,032

Changes in operating assets and liabilities:

Accounts receivable, net

(5,424

)

1,197

Other assets

(10,996

)

(7,416

)

Accounts payable, accrued and other liabilities

16,646

(16,478

)

Income taxes

(15,598

)

(4,505

)

Deferred revenue

7,213

14,870

Net cash provided by operating activities

174,725

149,310

Investing activities:

Purchase of property and equipment

(5,108

)

(4,871

)

Net cash used in investing activities

(5,108

)

(4,871

)

Financing activities:

Repurchase of common stock

(306,476

)

(186,638

)

Net cash used in financing activities

(306,476

)

(186,638

)

Foreign currency impact on cash

(5,778

)

6,562

Net change in cash and cash equivalents

(142,637

)

(35,637

)

Cash and cash equivalents at beginning of period

328,747

266,230

Cash and cash equivalents at end of period

$

186,110

$

230,593

MANHATTAN ASSOCIATES, INC.
SUPPLEMENTAL INFORMATION

1. GAAP and adjusted earnings per share by quarter are as follows:

2025

2026

1st Qtr

2nd Qtr

3rd Qtr

4th Qtr

Full Year

1st Qtr

2nd Qtr

YTD

GAAP Diluted EPS

$0.85

$0.93

$0.96

$0.86

$3.60

$0.82

$0.85

$1.67

Adjustments to GAAP:

Equity-based compensation

0.40

0.35

0.40

0.43

1.57

0.38

0.43

0.81

Tax deficiency (benefit) of stock awards vested

(0.06)

-

(0.01)

-

(0.06)

0.04

-

0.04

Unusual health insurance claim

0.04

-

-

-

0.04

-

-

-

Restructuring expense

(0.05)

0.04

-

(0.08)

(0.09)

-

0.11

0.10

Adjusted Diluted EPS

$1.19

$1.31

$1.36

$1.21

$5.06

$1.24

$1.39

$2.62

Fully Diluted Shares

61,527

61,074

60,954

60,642

61,054

60,038

58,997

59,515

2. Revenues and operating income by reportable segment are as follows (in thousands):

2025

2026

1st Qtr

2nd Qtr

3rd Qtr

4th Qtr

Full Year

1st Qtr

2nd Qtr

YTD

Revenue:

Americas

$194,615

$206,606

$206,659

$202,546

$810,426

$214,550

$227,012

$441,562

EMEA

55,542

52,301

53,975

53,978

215,796

53,663

55,378

109,041

APAC

12,630

13,514

15,161

13,865

55,170

14,002

15,404

29,406

$262,787

$272,421

$275,795

$270,389

$1,081,392

$282,215

$297,794

$580,009

GAAP Operating Income:

Americas

$33,862

$48,051

$45,783

$39,875

$167,571

$39,005

$41,336

$80,341

EMEA

23,703

19,807

22,877

21,686

88,073

19,670

18,122

37,792

APAC

5,607

5,930

7,168

5,451

24,156

6,262

6,773

13,035

$63,172

$73,788

$75,828

$67,012

$279,800

$64,937

$66,231

$131,168

Adjustments (pre-tax):

Americas:

Equity-based compensation

$28,826

$24,275

$27,577

$30,585

$111,263

$26,524

$29,356

$55,880

Unusual health insurance claim

(3,658)

3,000

-

(6,224)

(6,882)

-

-

-

Restructuring expense

2,929

8

-

-

2,937

-

5,637

5,637

$28,097

$27,283

$27,577

$24,361

$107,318

$26,524

$34,993

$61,517

EMEA:

Restructuring expense

-

-

-

-

-

-

2,346

2,346

APAC:

Restructuring expense

-

-

-

-

-

-

280

280

Adjusted non-GAAP Operating Income:

Americas

$61,959

$75,334

$73,360

$64,236

$274,889

$65,529

$76,329

$141,858

EMEA

23,703

19,807

22,877

21,686

88,073

19,670

20,468

40,138

APAC

5,607

5,930

7,168

5,451

24,156

6,262

7,053

13,315

$91,269

$101,071

$103,405

$91,373

$387,118

$91,461

$103,850

$195,311

3. Impact of Currency Fluctuation

The following table reflects the increases (decreases) in the results of operations for each period attributable to the change in foreign currency exchange rates from the prior period as well as foreign currency gains (losses) included in other income, net for each period (in thousands):

2025

2026

1st Qtr

2nd Qtr

3rd Qtr

4th Qtr

Full Year

1st Qtr

2nd Qtr

YTD

Revenue

$(1,591)

$2,724

$2,652

$3,833

$7,618

$5,975

$2,027

$8,002

Costs and expenses

(1,966)

1,180

738

906

858

2,646

(1,113)

1,533

Operating income

375

1,544

1,914

2,927

6,760

3,329

3,140

6,469

Foreign currency gains (losses) in other income

131

(65)

1,596

9

1,671

3,229

217

$3,446

$506

$1,479

$3,510

$2,936

$8,431

$6,558

$3,357

$9,915

Manhattan Associates has a large research and development center in Bangalore, India. The following table reflects the increases (decreases) in the financial results for each period attributable to changes in the Indian Rupee exchange rate (in thousands):

2025

2026

1st Qtr

2nd Qtr

3rd Qtr

4th Qtr

Full Year

1st Qtr

2nd Qtr

YTD

Operating income

$785

$514

$832

$1,409

$3,540

$1,045

$2,235

$3,280

Foreign currency gains (losses) in other income

15

140

1,978

742

2,875

3,449

730

4,179

Total impact of changes in the Indian Rupee

$800

$654

$2,810

$2,151

$6,415

$4,494

$2,965

$7,459

4. Other income includes the following components (in thousands):

2025

2026

1st Qtr

2nd Qtr

3rd Qtr

4th Qtr

Full Year

1st Qtr

2nd Qtr

YTD

Interest income

$1,101

$852

$1,007

$1,429

$4,389

$951

$753

$1,704

Foreign currency gains (losses)

130

(65)

1,597

9

1,671

3,229

217

3,446

Other non-operating income (expense)

106

(72)

-

(1)

33

157

13

170

Total other income (loss)

$1,337

$715

$2,604

$1,438

$6,094

$4,337

$983

$5,320

5. Capital expenditures are as follows (in thousands):

2025

2026

1st Qtr

2nd Qtr

3rd Qtr

4th Qtr

Full Year

1st Qtr

2nd Qtr

YTD

Capital expenditures

$891

$3,980

$5,928

$4,658

$15,457

$4,103

$1,005

$5,108

6. Stock Repurchase Activity (in thousands):

2025

2026

1st Qtr

2nd Qtr

3rd Qtr

4th Qtr

Full Year

1st Qtr

2nd Qtr

YTD

Shares purchased under publicly-announced buy-back program

539

263

233

416

1,451

1,043

874

1,917

Shares withheld for taxes due upon vesting of restricted stock

179

3

8

2

192

198

1

199

Total shares purchased

718

266

241

418

1,643

1,241

875

2,116

Total cash paid for shares purchased under publicly-announced buy-back program

$100,000

$49,596

$49,947

$74,996

$274,539

$149,983

$125,000

$274,983

Total cash paid for shares withheld for taxes due upon vesting of restricted stock

36,447

595

1,602

398

39,042

29,404

105

29,509

Total cash paid for excise tax

-

-

-

1,581

1,581

-

1,984

1,984

Total cash paid for shares repurchased

$136,447

$50,191

$51,549

$76,975

$315,162

$179,387

$127,089

$306,476

7. Remaining Performance Obligations

We disclose revenue that we expect to recognize from our remaining performance obligations ("RPO"). Over 99% of our RPO represents cloud native subscriptions with non-cancelable terms greater than one year (including cloud-deferred revenue as well as amounts we will invoice and recognize as revenue from our performance of cloud services in future periods). Maintenance contracts are typically one year and not included in the RPO. Our RPO as of the end of each period appears below (in thousands):

March 31, 2025

June 30, 2025

September 30,
2025

December 31,
2025

March 31, 2026

June 30, 2026

Remaining Performance Obligations

$1,891,384

$2,013,495

$2,076,628

$2,232,234

$2,347,952

$2,473,753

Michael Bauer

VP, Investor Relations

Manhattan Associates, Inc.

678-597-7538

[email protected]

Devika Goel

Director, Corporate Communications & PR

Manhattan Associates, Inc.

678-597-6754

[email protected]

Source: Manhattan Associates Inc.

Categories

Business Wire Press Releases